Format

Send to

Choose Destination
Eur J Endocrinol. 2011 Feb;164(2):157-67. doi: 10.1530/EJE-10-0754. Epub 2010 Nov 8.

Serum proteome changes in acromegalic patients following transsphenoidal surgery: novel biomarkers of disease activity.

Author information

1
Edison Biotechnology Institute, Ohio University, Athens, Ohio 45701, USA.

Abstract

CONTEXT:

Transsphenoidal adenomectomy is the primary treatment for acromegaly. However, assessment of the therapeutical outcome remains problematic since the existing biomarkers of disease activity frequently show discordant results.

OBJECTIVE:

To discover novel serum biomarkers of disease activity in acromegalic patients before and after surgery.

DESIGN:

Serum samples of eight newly diagnosed acromegaly patients before and after transsphenoidal surgery were analyzed for proteomic changes by two-dimensional gel electrophoresis. Protein spots displaying statistically significant changes, pre- versus post-surgery, were identified by mass spectrometry (MS), tandem MS (MS/MS), and western blot analysis.

RESULTS:

Six protein spots displaying decreased intensities after surgery were identified as transthyretin (two isoforms), haptoglobin α2, β-hemoglobin, and apolipoprotein A-1 (two isoforms). One protein spot, identified as complement C4B precursor, was increased after the surgery.

CONCLUSIONS:

Seven serum protein spots were differentially expressed following surgery in acromegalic patients. The identified proteins represent potential novel biomarkers to assess the effectiveness of surgical treatment in acromegalic individuals. Future studies will validate the use of the identified proteins as biomarkers of disease activity after medical treatment of acromegaly.

PMID:
21059862
PMCID:
PMC4074021
DOI:
10.1530/EJE-10-0754
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Sheridan PubFactory Icon for PubMed Central
Loading ...
Support Center